Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.
Weintraub WS, Culler SD, Kosinski A, Becker ER, Mahoney E, Burnette J, Spertus JA, Feeny D, Cohen DJ, Krumholz H, Ellis SG, Demopoulos L, Robertson D, Boccuzzi SJ, Barr E, Cannon CP. Weintraub WS, et al. Am J Cardiol. 1999 Feb 1;83(3):317-22. doi: 10.1016/s0002-9149(98)00860-1. Am J Cardiol. 1999. PMID: 10072215 Clinical Trial.
Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
Zhang Z, Weintraub WS, Mahoney EM, Spertus JA, Booth J, Nugara F, Stables RH, Vaccarino V. Zhang Z, et al. Among authors: weintraub ws. Am J Cardiol. 2004 Feb 15;93(4):404-9. doi: 10.1016/j.amjcard.2003.10.032. Am J Cardiol. 2004. PMID: 14969611 Clinical Trial.
The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z, Spertus JA, Mahoney EM, Booth J, Nugara F, Stables RH, Weintraub WS. Zhang Z, et al. Among authors: weintraub ws. Am Heart J. 2005 Jul;150(1):175-81. doi: 10.1016/j.ahj.2005.01.019. Am Heart J. 2005. PMID: 16084166 Clinical Trial.
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
Weintraub WS, Barnett P, Chen S, Hartigan P, Casperson P, O'Rourke R, Boden WE, Lewis C, Veledar E, Becker E, Culler S, Kolm P, Mahoney EM, Dunbar SB, Deaton C, O'Brien B, Goeree R, Blackhouse G, Nease R, Spertus J, Kaufman S, Teo K. Weintraub WS, et al. Am Heart J. 2006 Jun;151(6):1180-5. doi: 10.1016/j.ahj.2005.07.035. Am Heart J. 2006. PMID: 16781215
Effect of PCI on quality of life in patients with stable coronary disease.
Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group; Mancini GB. Weintraub WS, et al. N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771. N Engl J Med. 2008. PMID: 18703470 Free article. Clinical Trial.
660 results